Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-014558
Filing Date
2019-05-01
Accepted
2019-05-01 06:50:52
Documents
71
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20190331.htm 10-Q 1582937
2 EX-3.1 syrs-ex31_250.htm EX-3.1 169228
3 EX-31.1 syrs-ex311_9.htm EX-31.1 17645
4 EX-31.2 syrs-ex312_6.htm EX-31.2 17602
5 EX-32.1 syrs-ex321_8.htm EX-32.1 5961
6 EX-32.2 syrs-ex322_7.htm EX-32.2 6060
  Complete submission text file 0001564590-19-014558.txt   6573664

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syrs-20190331.xml EX-101.INS 1399420
8 XBRL TAXONOMY EXTENSION SCHEMA syrs-20190331.xsd EX-101.SCH 51466
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20190331_cal.xml EX-101.CAL 49482
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20190331_def.xml EX-101.DEF 169549
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20190331_lab.xml EX-101.LAB 398892
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20190331_pre.xml EX-101.PRE 325793
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 19784679
SIC: 2834 Pharmaceutical Preparations